F 0602
Protect each resident from the wrongful use of the resident's belongings or money.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
Observations, interviews, and record review, the facility failed to ensure the right to be free from
misappropriation of resident property for one of three residents (Resident #1) reviewed for
misappropriation.
Residents Affected - Few
The facility failed to prevent a diversion (misappropriation) of Resident #1's oxycodone HCl Oral Tablet 5
MG, 16 tablets (an oxycodone pain reliever) received through hospice and reported missing on 04/18/2025.
The noncompliance was identified as PNC. The non-compliance began on 04/10/2025 and ended on
04/28/2025. The facility had corrected the noncompliance before the survey began.
This failure could place residents at risk for decreased quality of life, unrelieved pain, misappropriation of
property, and dignity.
Findings included:
Review of Resident #1's face sheet printed 04/30/2025 reflected a [AGE] year-old female admitted to the
facility 12/04/2023. Her diagnoses included pain unspecified, chronic kidney disease stage 5, and other
osteoporosis with current pathological fracture of the femur (thigh bone).
Review of Resident #1's quarterly MDS assessment dated [DATE], Section C (Cognitive Patterns) reflected
a BIMS score of 08 indicating moderately impaired cognition. Section GG (Functional Abilities) reflected
she required maximal assistance with hygiene and bathing and only supervision with most other ADLs.
Section J (Health Conditions) the resident did not complain pain during the assessment period and was on
a scheduled pain medication regimen.
Review of Resident #1's comprehensive care plan, revised 06/13/24, the resident had an ADL self-care
performance deficit due to right femur fracture, weakness, comorbidities, osteoporosis, and was receiving
hospice services due to terminal illness.
Review of Resident #1's physician order reflected an order dated 08/28/2024 for oxycodone HCl Oral Tablet
5 MG (Oxycodone HCl) Give 1 tablet by mouth two times a day for Pain.
Review of Resident #1's physician order reflected an order dated 12/07/2023 for oxycodone HCl Oral Tablet
5 MG (Oxycodone HCl) Give 5 mg by mouth every 8 hours as needed for moderate to severe pain.
Review of Resident #1's medication administration record for April 2025, reflected no PRN dose of
Oxycodone was administered during the month.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
455785
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455785
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Avir at Western Hills
512 Draper Dr
Temple, TX 76504
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Review of the Provider Investigation Report dated 12/28/23 reflected, on 4/10/25, a nurse with Hospice
came to the facility and counted all medications for [Resident #1] and identified that resident had 16 PRN
5mg Oxycodone left in blister pack. On 4/18/25 around 11:30am, the same nurse with Hospice returned to
the facility and identified that the PRN 5mg oxycodone blister pack and respective narcotic count sheet was
not in the narcotic box or the narcotic book. At this time, nursing management attempted to find the
oxycodone blister pack and card count sheet but could not find the medication.
Observation on 04/30/2025 of the 300-hall nurse's narcotics book and cart, 200-hall medication aide and
nurse's narcotics book and cart were completed, all medications and blister packets were correct.
Review of facility's narcotics count sheet for the 200-hall reflected on 04/11/2025, there were 33 narcotic
blisters at the beginning of the 6am to 6 pm shift. The nurses removed a total of 7 medications blister
packet from the medication cart and the math was not done correctly, it reflected 25 packets instead of 26 .
During an interview on 04/30/2025 at 1:26 pm Resident #1 stated she was on routine pain medication.
Resident #1 stated she always got her pain medication when she needed it. Resident #1 stated she did not
have concerns with her pain medication.
During an interview on 04/30/2025 at 1:56 pm, the DON stated after the medication was noticed to be
missing, she counted all narcotics in the facility to verify counts. The DON stated Resident #1 was
assessed for pain and there was no adverse reaction for Resident #1. She stated Resident #1 never went
without pain medication because Resident #1's routine pain medication was on the medication aide cart.
The DON stated Resident #1 did not ask for PRN pain medication. The DON stated she initiated in-services
on the process on narcotics count and when the narcotics cart keys change hands. The DON stated she
initiated daily narcotic count monitoring of all carts in the facility. The DON stated she contacted the
pharmacy and narcotics reconciliation was done. The DON stated she was the only one who could remove
empty medication blister packets or discontinued medications from the medication cart. The DON stated 2
nurses were required to sign whenever the pharmacy delivered narcotics. The DON stated she suspected
Resident #1's oxycodone went missing on 4/11/2025 when there was mistake on the blister count.
During an interview on 04/30/2025 at 4:00 PM the Administrator stated he was made aware of the drug
diversion on 4/18/2025. The Administrator stated he called all staff who had access to the 200-hall
medication cart from 04/10/2025 to 4/18/2025 and they were interviewed and drug tested on [DATE] and all
were negative. The Administrator stated he notified the local police, but they did not show up. The
Administrator stated Resident #1's family and the Medical Director were notified. The Administrator stated
staff were in-serviced on 04/18/2025. He stated they were not able to identify a perpetrator but there was a
suspect. The Administrator stated the facility reordered Resident #1's oxycodone 16 tablets and paid for it
on 4/18/2025 .
During interviews on 04/30/2025 starting at 11:25am through 3:41 pm with 3 LVNs, 2 RNs, and 1 MA, they
all stated they were made aware there was drug diversion in the facility. They stated they were in-serviced
on the process of narcotics count and when the narcotics cart keys changed hands, the carts and
medications should be counted. They stated only the DON could remove empty medication blister packets
or discontinued medications from the medication cart. They stated 2 nurses were required to sign whenever
the pharmacy delivered narcotics .
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455785
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455785
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Avir at Western Hills
512 Draper Dr
Temple, TX 76504
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
Level of Harm - Minimal harm
or potential for actual harm
Review of the facility's investigation reflected the Quality Assurance Performance Improvement team met
on 04/18/2025 at 4:18 pm.
Review of facility's investigation folder reflected Police REPORT NUMBER: CL25040088 DATE: 04/18/2025
at 4:45 pm.
Residents Affected - Few
Review of facility's in-services date 04/18/2025 reflected:
In-Service for Narcotic Count and Medication Reconciliation
For all Licensed Charge Nurses and Certified Medication Aides
Beginning 4/18/25 and ongoing, all nurses and medication aides will continue the existing card count sheet
and narcotic count sheet already in play. In addition, the following parameters will be put into action.
Effective Immediately, medication cards need to remain in the medication cart, even if completely depleted,
until the DON reviews the Narcotic Count and Narcotic Card Counts for these medications. If a Nurse or
Medication Aide dispenses the final dose of a medication in the blister pack, the employee must put the
card back into the medication cart and it will be counted in the card count completed at the end/beginning
of the shift. Only the Director of Nursing may remove any card from the medication cart. All blister cards, full
and empty, must remain on the cart and only the Director of Nursing may remove empty blister packs from
the medication cart.
Effective Immediately, all narcotics will require 2 nurse's signatures when accepting them from the
pharmacy. When pharmacy brings narcotics to the nurse's station, two nurses must sign off on the Narcotic
acceptance form (attached to this in-service). This is to ensure verification by two licensed nurses that the
medication has been delivered and the quantity is accurately reported in the narcotic count sheet. All
information must be filled in - Resident Name, medication name, dose, acceptance date, and quantity .
Review of the facility's investigation folder reflected daily monitoring of narcotics count done by the DON for
all carts in the facility initiated 04/18/2025 and was ongoing.
Review of facility's investigation folder reflected: All 6 employees who were assigned to the 200-hall
medication cart between 04/10/2025 and 04/18/2025 where the drug diversion occurred were suspended
pending consensual drug screen. It was reflected all 6 staff were drug screened on 4/18/2025 and all came
up negative. All 6 nurses were interviewed by the Administrator.
Review of the facility's investigation folder reflected:
Controlled Substance Audit-- A controlled substance audit was performed at the request of the facility. The
audit included 8 medication/nurse carts, 4 from each wing. Medication orders were reconciled against all
active orders dated 4/22/2025 from the nursing home EHR . Controlled substances were audited for expired
medications, medication orders with discrepancies, residents with medication orders without medications
on-hand, and medications found without an active order. Facility was notified of issues and concerns upon
exiting with nurse supervisors, with specific details provided by the end of day completed with this report.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455785
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
455785
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/30/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Avir at Western Hills
512 Draper Dr
Temple, TX 76504
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Review of the facility's in-services reflected an in-service dated 4/28/2025 Card/Narcotic count when keys
change hands which was on going.
Review of the facility policy Identifying Exploitation, Theft, and Misappropriation of Resident Property dated
April 2021 reflected in part, 1. Exploitation, theft, and misappropriation of resident property are strictly
prohibited. 4. Misappropriation of resident property means the deliberate misplacement, exploitation or
wrongful, temporary, or permanent use of a resident's belongings or money without the resident's consent.
5. Examples of misappropriation of resident property include: f. drug diversion (taking the resident's
medication).
Review of the facility's policy titled Drug Discrepancies, Loss, or Diversion dated reflected:
The facility will comply with all federal, state, and local laws as it pertains to dangerous drugs and
controlled substances. The facility must have a system that records receipt, usage, and disposition of all
controlled substances in sufficient detail that permits an accurate reconciliation. See sections 8.3 Schedule
Medication Inventory Sheets and 8.4 Destruction of Scheduled Medication of the Policies and Procedures
for Pharmacy Services for additional information regarding those processes. Drug diversion (as defined in
The State Operating [NAME]): is the transfer of a controlled substance or other medication from a lawful to
an unlawful channel of distribution or use, as adapted from the Uniform Controlled Substances Act.
Review of the facility's policy titled Abuse, Neglect, Exploitation and Misappropriation Prevention Program
revised April 2021 reflected:
Residents have the right to be free from abuse, neglect, misappropriation of resident property and
exploitation. This includes but is not limited to freedom from corporal punishment, involuntary seclusion,
verbal, mental, sexual or physical abuse, and physical or chemical restraint not required to treat the
resident's symptoms.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
455785
If continuation sheet
Page 4 of 4